Biosafety Protocol Submission & Approval
Click the button above to visit BioRAFT.
As of December 2016, EHSO completed the transition from paper forms to electronic registrations using BioRAFT.
Amendments to add biological agents should be done by going to the electronic registration page and completing the appropriate surveys or forms. The following are some examples:
|Item to Add||What to Complete in BioRAFT|
|Human Source Materials (e.g. human cell lines)||
|Pathogen, Risk 2 Group and Above||
|Any Viral Vector (e.g. baculovirus)||
Note: This table is just a list of examples and is not a comprehensive list.
2017 Annual Updates
- Complete the Hazard Assessment checklist
- Check personnel list is up to date; contact firstname.lastname@example.org if you need to add an individual*
- Upload Corrective Action Plan for the next calendar year
- Review surveys and forms for needed biological agents. If PI has more than one project form (i.e. more than one biosafety approval), all project forms should be reviewed during the update.
- Click Certify
- Ensure that all personnel have updated their training and have provided Hepatitis B documentation, if applicable
- Complete Hazardous Chemicals Registration Wizard
- Once you reach the end of the survey, you will have the option of adding the highly hazardous chemicals in your lab
- Click Certify
*To add personnel, send full name of individual and project number to email@example.com. The Research Safety program will check training and Hepatitis B documentation (if applicable), add name to electronic registration, and issue the amended approval letter.
**If a new project needs to be added, please contact firstname.lastname@example.org to request access to BioRAFT.
Requiring Biosafety Protocol Submission
Principal Investigators (PIs) who intend to work with any of the following, but not limited to, in vitro or in vivo, require protocol submission:
- Bacteria (infectious and non infectious)
- Viruses (infectious and non infectious)
- Human blood, body fluid, cell lines, fixed and unfixed tissue or Other Potentially Infectious Materials (OPIM)
- Recombinant/synthetic nucleic acid molecules
- Biological Toxins
- Other Biological/Infectious Material (Prions, Parasites, Fungi)
- Non-Human Primate Material
Institutional Biosafety Committee (IBC)
Research Health and Safety Committee (RHSC)
- rDNA Experiments Covered by the NIH Guidelines
- IBC and RHSC Review Process
- Guidelines to Work With Viral Vectors